Chugai Pharma Usa, Inc.

Chugai Pharma Usa, Inc. company information, Employees & Contact Information

Chugai’s strength in R&D and antibody technologies continues on in global efforts for products and services for the benefit of patients. Chugai Pharma USA, Inc. (CPUSA), located in Berkeley Heights, NJ, is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. (Chugai). CPUSA supports the planning and execution of global and U.S. clinical programs for Chugai-originated, innovative new drug candidates. Chugai is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs in Chugai’s strategic fields of oncology, bone and joint diseases, and renal diseases as well as other therapeutic areas with serious unmet needs. Chugai develops its products independently from Roche until early Proof-of-Concept (PoC) for worldwide market, including U.S. For late stage clinical development and marketing outside of Japan, South Korea, and Taiwan, Chugai seeks for partnership with Roche, which has the first refusal rights to develop/sell Chugai products, or other third parties. For a list of Chugai’s current research projects please visit: http://www.chugai-pharm.co.jp/english/ir/reports_downloads/pipeline.html

Company Details

Employees
236
Phone
81 3 3281 6611
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Looking for a particular Chugai Pharma Usa, Inc. employee's phone or email?

Chugai Pharma Usa, Inc. Questions

News

Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st

Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now simplywall.st

Renalys Pharma to be Acquired by Chugai Pharmaceutical - citybiz

Renalys Pharma to be Acquired by Chugai Pharmaceutical citybiz

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma - Reuters

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma Reuters

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing - Yahoo Finance

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing Yahoo Finance

AWS Collaborates with Chugai Pharmaceutical Co. on Quantum-Inspired and Constraint Programming Methods for Cyclic Peptide-Protein Docking - Amazon Web Services

AWS Collaborates with Chugai Pharmaceutical Co. on Quantum-Inspired and Constraint Programming Methods for Cyclic Peptide-Protein Docking Amazon Web Services

What To Expect From Chugai Pharmaceutical Co Ltd (TSE:4519) Q3 2 - GuruFocus

What To Expect From Chugai Pharmaceutical Co Ltd (TSE:4519) Q3 2 GuruFocus

How Chugai Pharmaceutical Co. Ltd. (CUP) stock trades after rate cuts - July 2025 Momentum & Consistent Return Investment Signals - Fundação Cultural do Pará

How Chugai Pharmaceutical Co. Ltd. (CUP) stock trades after rate cuts - July 2025 Momentum & Consistent Return Investment Signals Fundação Cultural do Pará

Message from the CEO | Company Outline | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

Message from the CEO | Company Outline | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Chugai and Gero Enter into Joint Research and License - GlobeNewswire

Chugai and Gero Enter into Joint Research and License GlobeNewswire

Up to $1.085B deal: Rani Therapeutics partners with Chugai on oral biologics; $60.3M PIPE - Stock Titan

Up to $1.085B deal: Rani Therapeutics partners with Chugai on oral biologics; $60.3M PIPE Stock Titan

How Chugai Pharmaceutical Co. Ltd. (CUP) stock trades after rate cuts - 2025 Geopolitical Influence & Safe Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia

How Chugai Pharmaceutical Co. Ltd. (CUP) stock trades after rate cuts - 2025 Geopolitical Influence & Safe Entry Point Alerts Trung tâm Dự báo KTTV quốc gia

Chugai Sinks Most Since 1977 on Obesity Drug Disappointment - Bloomberg.com

Chugai Sinks Most Since 1977 on Obesity Drug Disappointment Bloomberg.com

Feb 20,2025 | Awarded - chugai-pharm.co.jp

Feb 20,2025 | Awarded chugai-pharm.co.jp

Earnings To Watch: Chugai Pharmaceutical Co Ltd (TSE:4519) Reports Q2 2025 Result - Yahoo Finance

Earnings To Watch: Chugai Pharmaceutical Co Ltd (TSE:4519) Reports Q2 2025 Result Yahoo Finance

Quarterly Trades: Will Chugai Pharmaceutical Co. Ltd. (CUP) stock beat growth indexes - Market Movers & Community Verified Watchlist Alerts - Trung tâm Dự báo KTTV quốc gia

Quarterly Trades: Will Chugai Pharmaceutical Co. Ltd. (CUP) stock beat growth indexes - Market Movers & Community Verified Watchlist Alerts Trung tâm Dự báo KTTV quốc gia

Top Management Commitment | Chugai’s Sustainability | Sustainability | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

Top Management Commitment | Chugai’s Sustainability | Sustainability | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Contributing to Global Environmental ProtectionEfforts to Protect Water Resources at Our Production Sites, 2024 - chugai-pharm.co.jp

Contributing to Global Environmental ProtectionEfforts to Protect Water Resources at Our Production Sites, 2024 chugai-pharm.co.jp

Message from the CEOs | Chugai Pharmaceutical 100th Anniversary Site | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

Message from the CEOs | Chugai Pharmaceutical 100th Anniversary Site | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals - chugai-pharm.co.jp

Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals chugai-pharm.co.jp

Sentiment Recap: Can Chugai Pharmaceutical Co. Ltd. (CUP) stock retain market dominance - Trade Performance Summary & Growth-Oriented Investment Plans - Trung tâm Dự báo KTTV quốc gia

Sentiment Recap: Can Chugai Pharmaceutical Co. Ltd. (CUP) stock retain market dominance - Trade Performance Summary & Growth-Oriented Investment Plans Trung tâm Dự báo KTTV quốc gia

Rani Therapeutics Announces Research Agreement with Chugai - Yahoo Finance

Rani Therapeutics Announces Research Agreement with Chugai Yahoo Finance

Chugai to Construct a New Laboratory Building “UKX” to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives toward TOP I 2030 - FirstWord Pharma

Chugai to Construct a New Laboratory Building “UKX” to Strengthen Manufacturing Process Development Capabilities and Advance Environmental Initiatives toward TOP I 2030 FirstWord Pharma

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment: Press Releases - NEC Global

NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment: Press Releases NEC Global

Chugai Pharmaceuticals’ AI Strategy: Analysis of Dominance in Pharma AI - Klover.ai

Chugai Pharmaceuticals’ AI Strategy: Analysis of Dominance in Pharma AI Klover.ai

Recovery of a Peptide Intermediate from a Reaction Mixture Contaminated with a Large Quantity of Silicone Oil Coolant - ACS Publications

Recovery of a Peptide Intermediate from a Reaction Mixture Contaminated with a Large Quantity of Silicone Oil Coolant ACS Publications

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy - Yahoo Finance

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy Yahoo Finance

Chugai stock drops the most since 1977 on disappointing obesity drug data - The Japan Times

Chugai stock drops the most since 1977 on disappointing obesity drug data The Japan Times

2024 Contribution of Para-transit Vehicles to Welfare Services - chugai-pharm.co.jp

2024 Contribution of Para-transit Vehicles to Welfare Services chugai-pharm.co.jp

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology - GlobeNewswire

Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology GlobeNewswire

J.P. Morgan Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $62.93 - 富途牛牛

J.P. Morgan Maintains CHUGAI PHARMACEUTICAL CO(CHGCF.US) With Buy Rating, Raises Target Price to $62.93 富途牛牛

Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron - TipRanks

Chugai Highlights Eli Lilly’s Positive Phase 3 Results for Orforglipron TipRanks

Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai - The Japan Times

Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai The Japan Times

Chugai and GSK collaborate to advance AID-351 for dengue - BioWorld MedTech

Chugai and GSK collaborate to advance AID-351 for dengue BioWorld MedTech

Apr 25,2022 | Organizational and Personnel Changes | News | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

Apr 25,2022 | Organizational and Personnel Changes | News | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Construction of Chugai’s New Research Center “Chugai Life Science Park Yokohama” Reached Completion - chugai-pharm.co.jp

Construction of Chugai’s New Research Center “Chugai Life Science Park Yokohama” Reached Completion chugai-pharm.co.jp

Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

Strategic Alliance with Roche | Our Strategy | About Chugai | CHUGAI PHARMACEUTICAL CO., LTD. chugai-pharm.co.jp

Disclosures based on the TCFD recommendations - chugai-pharm.co.jp

Disclosures based on the TCFD recommendations chugai-pharm.co.jp

Clinical Trials Arena Excellence Awards 2023: Chugai Pharmaceutical - Clinical Trials Arena

Clinical Trials Arena Excellence Awards 2023: Chugai Pharmaceutical Clinical Trials Arena

Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor - ACS Publications

Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor ACS Publications

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain - PR Newswire

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain PR Newswire

New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD - Neurology® Journals

New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD Neurology® Journals

Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure | National Cancer Center Japan - ncc.go.jp

Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure | National Cancer Center Japan ncc.go.jp

Chugai Pharmaceutical Co Ltd (TSE:4519) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus

Chugai Pharmaceutical Co Ltd (TSE:4519) Q3 2024 Earnings Report Preview: What to Expect GuruFocus

Feature: 2. Working to make Chugai synonymous with oncology - chugai-pharm.co.jp

Feature: 2. Working to make Chugai synonymous with oncology chugai-pharm.co.jp

Halozyme Therapeutics, Inc. and Chugai Pharmaceutical Enter Global Collaboration and License Agreement for ENHANZE® Technology - PR Newswire

Halozyme Therapeutics, Inc. and Chugai Pharmaceutical Enter Global Collaboration and License Agreement for ENHANZE® Technology PR Newswire

BPS Publications - British Pharmacological Society | Journals

BPS Publications British Pharmacological Society | Journals

BPS Publications - British Pharmacological Society | Journals

BPS Publications British Pharmacological Society | Journals

Chugai Pharma to Construct Two New Manufacturing Facilities at Utsunomiya Plant - ChemAnalyst

Chugai Pharma to Construct Two New Manufacturing Facilities at Utsunomiya Plant ChemAnalyst

BPS Publications - British Pharmacological Society | Journals

BPS Publications British Pharmacological Society | Journals

Chugai's FJ2 Project, designed and constructed by JGC JAPAN CORPORATION, was selected as Winner of the Innovation Category of the Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE) | News Releases 2023 | - jgc.com

Chugai's FJ2 Project, designed and constructed by JGC JAPAN CORPORATION, was selected as Winner of the Innovation Category of the Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE) | News Releases 2023 | jgc.com

Roche, Chugai Pharma to transfer Bonviva business in Japan to Taisho Pharma - Medical Dialogues

Roche, Chugai Pharma to transfer Bonviva business in Japan to Taisho Pharma Medical Dialogues

Chugai Pharma conducts digital transformation for manufacturing function - BioSpectrum Asia

Chugai Pharma conducts digital transformation for manufacturing function BioSpectrum Asia

Chugai Pharmaceutical Co. - Singapore Economic Development Board (EDB)

Chugai Pharmaceutical Co. Singapore Economic Development Board (EDB)

Chugai Pharma Opens $200m Antibody Lab In Singapore - Asian Scientist Magazine

Chugai Pharma Opens $200m Antibody Lab In Singapore Asian Scientist Magazine

Chugai Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists - ANSA

Chugai Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists ANSA

Top Chugai Pharma Usa, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant